Trials / Completed
CompletedNCT06699940
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
A Retrospective Registry Study to Evaluate Application of NeuroStar® Advanced Therapy for Depression and Comorbid Anxiety in Adolescents
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,690 (actual)
- Sponsor
- Neuronetics · Academic / Other
- Sex
- All
- Age
- 12 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
To assess the real-world effectiveness of transcranial magnetic stimulation (TMS) for depression in large adolescent and young adult samples.
Detailed description
This is a retrospective analysis. The purpose of this study is to collate real world data (RWD) from existing medical records of patients aged 12 to 21 years who received treatment with NeuroStar Advanced Therapy for Major Depressive Disorder (MDD) as determined by scores on the PHQ-9 and CGI-S assessment tool into a central registry database.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Magnetic Stimulation | Patients between the age of 12-21 received TMS treatment for MDD disorder. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2024-11-21
- Last updated
- 2025-01-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06699940. Inclusion in this directory is not an endorsement.